Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

FOLLOW US: 

March 29, 2019

Multi-million Dollar Settlement Reached Over Opioid Debacle

$270 million settlement with Purdue Pharmaceuticals offers hope to those struggling with an opioid addiction.

On Tuesday March 26, Oklahoma settled it 2017 lawsuit with Purdue Pharma LP and members of the Sackler family, owners of Purdue and makers of the popular painkiller OxyContin. The state of Oklahoma accused the drug maker of spurring the opioid abuse epidemic in the U.S. through deceptively marketing painkillers, the lawsuit led by Oklahoma Attorney General Mike Hunter.

Members of Oklahoma communities may get the medical help and emotional support they need through new plans for a opioid addiction treatment center at OSU.

In 2017 the U.S. Department of Health and Human Services (HHS) declared a public health emergency after the widespread misuse of non-prescriptive and prescriptive opioids swept across America. Consumers quickly became highly addicted to the pain relievers despite some opioid manufacturers' denial of opioids' addictive qualities.

Johnson & Johnson and Teva Pharmaceutical Industries Ltd. were also part of Hunter's original allegations. Hunter asserted that these companies (along with Purdue) overstated the benefits of opioids while underplaying the risk of addiction, therefore engaging in deceptive marketing practices.

The numbers seem to support Hunter's case: the HHH reports that in 2017 a staggering 11.4 million Americans misused prescription opioids, and 2.1 million people in the U.S. struggled with an opioid use disorder.

Additionally, a Purdue scandal in 2007 lends to Hunter's allegations. After pleading guilty to misbranding OxyContin, Purdue and three executives paid $634.5 million in penalties for the federal charges.

On May 28, 2019 the lawsuit was set to go before a jury, but the settlement came first after Purdue's chief executive reported the company was considering filing for bankruptcy protection. This strategy may have been implemented to address possible liabilities from the opioid lawsuits.

While Oklahoma sought over $20 billion in damages, the settlement will help fund an addiction treatment center at Oklahoma State University, with $20 million worth of medications donated to support treatment. At a news conference, Hunter said the new treatment center "is going to save countless lives, and it's going to keep families together."

The Sackler family still maintain that allegations of their contribution to the opioid crisis are inaccurate. Members of the prestigious family asserted taht the Oklahoma settlement does not set precedence for possible settlements in the future. People following the case closely commented that Purdue may try to attempt settlements with other local and state governments filing similar lawsuits to Oklahoma's. But, they have not eliminated the option of filing for bankruptcy just jet.

Settlement Breakdown


The details of the opioid settlement include the following specifications:

  • $102.5 million to aid in funding the addiction treatment center at OSU
  • $20 million worth of medications donated to support treatment
  • The Sacklers contributed $75 million towards the treatment center, though they were not named as defendants in the Oklahoma lawsuit
  • $12.5 million towards Oklahoma localities to aid in addressing opioid epidemics in the community
  • $60 million towards costs and legal fees derived from the lawsuit

While the outcome of future lawsuits and possible opioid settlements with pharmaceutical giants like Purdue still hang in the air, the Oklahoma settlement allows for a spark of hope and a pathway towards healing for those impacted by the opioid epidemic.

Recent Posts

Truvada Lawsuit Filed for Dangerous Side Effects of Tenofovir HIV Drugs

Allegations brought forward in a recent product liability lawsuit call out Gilead Sciences, Inc. for the dangerous side effects of their tenofovir-based HIV drugs, which include Truvada, Stribild, and Viread. Numerous lawsuits from across the U.S. allege tenofovir HIV drugs cause users to experience severe side effects, including kidney and bone injuries. Last week a […]

Read More
3M Earplug Bellwether Trial Scheduled for April 2021 Over Military Hearing Loss

The judge presiding over all federal 3M military earplug lawsuits announced that the first “bellwether” case in the litigation will go to trial April 5, 2021. This case, like the thousands of others in the litigation, allege 3M’s military earplugs were defective and caused veterans to suffer hearing severe injuries. Currently, over 150,000 earplug injury […]

Read More

Contact Us Today for your free, in-depth case evaluation

We're on Your Side
We're available 24/7
no fees unless you win

Free in-depth 
no obligation case evaluation

ATTORNEY ADVERTISEMENT: Not available in all states, Andrew Van Arsdale, supervising attorney is licensed only in California, Montana and Nevada, but associates with attorneys throughout the country, Principal office: 3667 Voltaire Street, San Diego, California 92106. 

Consult a doctor on all medical decisions. Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. No representation is made that the quality of the legal services performed is greater than the quality of the legal services performed by other lawyers. AVA Law Group, Inc. not accepting cases in states where this advertising conflicts with laws or state rules. Legal representation is not offered or available in Tennessee. While AVA Law Group, Inc. maintains joint responsibility, most cases are referred to other attorneys for principal responsibility.
envelopephone-handsetmap-markerarrow-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram